Respiratory
10 drugs are in development for Pulmonary Arterial Hypertension.
- Companies
- 9
- Clinical trials
- 34
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Pulmonary Arterial Hypertension pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(6)
Preclinical(3)
| Drug | Company |
|---|---|
| av-101 | Jade Biosciences, Inc. (JBIO) |
| CM5480 | CalciMedica, Inc. (CALC) |
| elafin | PROTEO INC (PTEO) |
BLA Filed(1)
| Drug | Company |
|---|---|
| trevyent | STEADYMED LTD. (STDY) |
About this indication
Pulmonary Arterial Hypertension context
Respiratory·MeSH: Pulmonary Arterial Hypertension (D000081029)
Incidence
2.4 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Pulmonary Arterial Hypertension?
BioSniper tracks 10 drugs in development for Pulmonary Arterial Hypertension across 9 companies.
How many clinical trials target Pulmonary Arterial Hypertension?
There are 34 clinical trials targeting Pulmonary Arterial Hypertension tracked by BioSniper.